Citigroup Maintains Cardinal Health Inc to Neutral with Price Target $93.00

Brokerage firm Citigroup Maintains its rating on Cardinal Health Inc(NYSE:CAH). In a research note issued to the investors, the brokerage major Raises the price-target to $93.00 per share. The shares have been rated Neutral. The rating by Citigroup was issued on Aug 3, 2016.

In a different note, On Jun 7, 2016, Bank of America said it Reinstates its rating on Cardinal Health Inc. The shares have been rated ‘Neutral’ by the firm.

Cardinal Health Inc (CAH) shares turned negative on Fridays trading session with the shares closing down -0.01 points or -0.01% at a volume of 10,25,632. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $83.66. The peak price level was also seen at $83.66 while the days lowest was $83.12. Finally the shares closed at $83.6. The 52-week high of the shares is $91.225 while the 52-week low is $73.2523. According to the latest information available, the market cap of the company is $27,238 M.

Cardinal Health Inc(CAH) last announced its earnings results on Aug 2, 2016 for Fiscal Year 2016 and Q4.Company reported revenue of $31.38B. Analysts had an estimated revenue of $31.17B. Earnings per share were $1.14. Analysts had estimated an EPS of $1.13.

Several Insider Transactions has been reported to the SEC. On May 23, 2016, Carole S Watkins (Chief HR Officer) sold 84,617 shares at $77.33 per share price.Also, On Nov 12, 2015, George S Barrett (Chairman and CEO) sold 54,658 shares at $87.73 per share price.On Nov 9, 2015, Falk T Stephen (EVP, Gen. Counsel & Corp. Sec.) sold 30,085 shares at $87.66 per share price, according to the Form-4 filing with the securities and exchange commission.

Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Cardinal Health Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Cardinal Health Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.